Agilent Technologies, Inc.

NYSE:A

Medical - Diagnostics & Research

Healthcare
$177.33 +2.44%

+$3.04 today

Market cap
$50.00B
Beta
1.26
P/E (TTM)
25.5
EPS (TTM)
$5.00
Dividend yield
0.59%
52W Low $108.35High $160.27

Volume 2.48M

Average 2.24M

A EBITDA Margin

EBITDA as a percentage of revenue.

Agilent Technologies, Inc.NYSE: A

EBITDA Margin · Q3 FY2026 · quarter ended Jul 2026

EBITDA Margin widens to 28.7%

EBITDA Margin was 28.7% in Q3 FY2026, up 1.9 pp from a year earlier. On a trailing-twelve-month basis it was 27.6%, up 1.1 pp year over year. Over 3 fiscal years it narrowed by 1.4 pp.

Context

  • EBITDA Margin widened in 1 of the last 3 fiscal years.

What to watch

Whether EBITDA Margin reaches the consensus estimate from 15 analysts of 32.5% for the fiscal year ending Oct 2026, up from 26.4% in FY2025.

Sources:Income Statement Analyst consensus estimates Text generated from reported figures; not investment advice.

Latest quarterJul 2026
28.7%+1.5 pp QoQ
Last fiscal yearOct 2025
26.4%-2.4 pp YoY
LTMJul 2026
27.6%+1.1 pp YoY
EBITDA Margin past and forecast change by horizon
Horizon Past Forecast Difference
Quarter+1.9 pp+3.6 pp+1.7 pp
1 year-2.4 pp+6.1 pp+8.4 pp
3 years-1.4 pp+6.5 pp+7.9 pp
5 years+9.9 pp—
10 years——

Forecasts compare the consensus estimate with the latest reported period. Difference is forecast minus past, in percentage points.

EBITDA Margin history

Percent of revenue · from the income statement

Latest · FY2025
26.4%
Year-over-year change
-2.4pp
Reported Analyst consensus estimate Further estimates hidden. Sign in to unlock

EBITDA Margin vs competitors

How A compares with its peers on the latest reported figures

  • A's LTM Jul 2026 EBITDA Margin of 27.6% is the 4th highest of the 9 companies compared; the peer median is 25.0%.
  • Its year-over-year change of +1.1 pp is the highest of 9, against a peer median of -2.6 pp.
  • Over three fiscal years its change of -1.4 pp compares with a peer median of -2.2 pp.
A Competitors Peer median
EBITDA Margin for A and competitors
Company Period LTM level YoY 3-year change
QGENQiagen N.V.LTM Jun 202633.5% -1.6 pp-2.1 pp
MTDMettler-Toledo International Inc.LTM Jun 202631.6% +0.0 pp-0.7 pp
DHRDanaher CorporationLTM Sep 202627.7% -0.6 pp-7.3 pp
AAgilent Technologies, Inc.LTM Jul 202627.6% +1.1 pp-1.4 pp
RVTYRevvity, Inc.LTM Jul 202626.3% -3.0 pp-8.9 pp
TMOThermo Fisher Scientific Inc.LTM Sep 202623.7% -2.2 pp-0.9 pp
WATWaters CorporationLTM Jul 202620.5% -14.2 pp-2.3 pp
BIOBio-Rad Laboratories, Inc.LTM Jun 202619.9% -6.2 pp+208.5 pp
BRKRBruker CorporationLTM Jun 20267.1% -4.6 pp-11.7 pp
Peer median (excluding A) 25.0%-2.6 pp-2.2 pp

Competitors are the stored peer set for A. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Income Statement

USD
Metric
FY2021
Oct 2021
FY2022
Oct 2022
FY2023
Oct 2023
FY2024
Oct 2024
FY2025
Oct 2025
Revenue6.32B6.85B6.83B6.51B6.95B
Cost of Revenue2.91B3.13B3.37B2.98B3.31B
Gross Profit3.41B3.72B3.47B3.54B3.64B
Gross Margin53.9%54.4%50.7%54.3%52.4%
Research & Development441M467M481M479M455M
Selling, General & Admin1.62B1.64B1.63B1.52B1.71B
Operating Expenses2.06B2.1B2.12B2.05B2.16B
Depreciation & Amortization321M317M271M257M288M
EBITDA1.76B1.91B1.7B1.87B1.84B
EBITDA Margin27.9%27.8%24.9%28.8%26.4%
Operating Income1.35B1.62B1.35B1.49B1.48B
Operating Margin21.3%23.6%19.8%22.9%21.3%
Interest Income2M9M51M80M62M
Interest Expense81M84M95M96M112M
Other Income / Expenses13M(114M)(11M)33M(44M)
Income Before Tax1.36B1.5B1.34B1.52B1.44B
Pre-Tax Margin21.5%22.0%19.6%23.4%20.7%
Income Tax Expense150M250M99M232M132M
Net Income1.21B1.25B1.24B1.29B1.3B
Net Margin19.1%18.3%18.1%19.8%18.8%
EPS (Basic)3.984.194.224.444.59
EPS (Diluted)3.944.184.194.434.57
Weighted Avg Shares304M299M294M290M283M
Weighted Avg Shares (Diluted)307M300M296M291M284M

Agilent Technologies, Inc.

NYSE:A

Intrinsic Alpha fair value

Locked

Current Price

$177.33

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.